Philipp Koellinger, CEO and co-founder of open science pioneer DeSci Labs, explains the reshaping of the scientific publishing landscape and explores what it means for scientists worldwide.
ProBioGen has announced an agreement with Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars.
Isarna Therapeutics presented final positive results from its Phase II BETTER trial at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting on 6th May.
For manufacturers facing production challenges, renting product inspection systems can be a cost-effective, flexible solution. Christine Gottschalk, head of PI Test and Demo Center at Mettler-Toledo, discusses the benefits of rental technologies.
Bionova Scientific has announced it has licensed ATUM’s proprietary Leap-In Transposase transposon-based gene delivery and its miCHO cell line development technologies.
NewBiologix has announced it has granted a non-exclusive technology license to ReciBioPharm to provide global biotech and pharma companies with access to NewBiologix’s Xcell-Eng-HEK293 cell lines.
Antares Vision Group, has expanded its solutions portfolio to include precision labelling equipment, through a partnership with Italy-based Siempharma.
Astraveus, the benchtop cell factory company, has announced that it has entered into a strategic partnership with The Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen).
Aptamer Group, a developer of next-generation synthetic binders, has announced the adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent Assay (ELISA).
Aptar CSP Technologies, part of AptarGroup, has announced the expansion of its service offerings with the launch of a cGMP-compliant manufacturing facility in New Jersey.
